Dr. Wu is the US Head of Business Development (BD) at Adlai Nortye USA Inc., a clinical stage biopharmaceutical company. He is responsible for search & evaluation, due diligence, and transaction of preclinical and clinical stage business development opportunities in the USA.
Before Adlai Nortye, he was the Manager of Commercial Partnerships at ATCC, one of the world largest biological resource centers. He was responsible for prospecting and developing new commercial and strategic partnership opportunities through engagements with external partners, contract term negotiations and preparations for major commercial transactions and agreements with business-to-business partners and other commercial customers.
Prior to joining ATCC, Dr. Wu worked as the Sales & Marketing Manager of Discovery Biology Business Unit at GenScript USA. He led the global commercial team including marketing, sales, and customer care to support pharmaceutical and biotech clients’ Drug Discovery needs, and was responsible for the strategy, planning, and execution of marketing and sales plans to build brand recognition and achieve financial goals.
Dr. Wu obtained his PhD degree from North Carolina State University.